Spyridon Gkalpakiotis

28PUBLICATIONS
58CO-AUTHORS
Gene and molecular therapyPreventative health carePharmacogenomicsEpidemiological methodsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 27, 2026
A Delphi Consensus on Tildrakizumab Dosing and Titration in Moderate-to-Severe Plaque Psoriasis.

|Mar 03, 2025
Analysis of PEST Questionnaire Responses in Patients with Psoriasis in Daily Practice: Results from a Single-Center of Psoriasis in the Czech Republic.

Simona Tivadar, Jan Hugo, Kristína Fuzesiová

|Jun 11, 2024
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study.

Andrea Chiricozzi, Giulia Coscarella, Luis Puig

|May 03, 2024
Real-World Clinical, Psychosocial, and Economic Burden of Atopic Dermatitis: Results From the ESSENTIAL AD Multicountry Study.

Spyridon Gkalpakiotis, Susanna Kannenberg, Külli Kingo

|Nov 30, 2023
Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic.

Spyridon Gkalpakiotis, Martina Kojanová, Jorga Fialová

|Sep 06, 2022
Efficacy of switches within the class of IL-17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy (BIOREP).

Martin Tichy, Martina Kojanova, Barbora Velackova

Pageof 5

Frequent Collaborators

6 joint publications

Monika Arenbergerova

3 joint publications

Martina Kojanova

2 joint publications

P Arenberger

2 joint publications

Francesca Prignano